Description

Requirements

Download the Study Worksheet. Research and answer the questions below as you explore the Week 2 module and requirements. Enter your responses in the Week 2 Quiz by Sunday at 11:59 p.m. MT. Do not submit this form; complete the Quiz using the answers from the Study Worksheet. 

1. Question: Adding epinephrine to a local anesthetic, such as 1% lidocaine for local infiltration, has which of the following benefits?
2. Question: Your patient reports a history of anaphylaxis to an “ester-type” local anesthetic. Which of the following, if given, would be most likely to provoke an allergic response in this patient?
3. Question: An OR patient receives propofol for induction. What is the most likely adverse response associated with the administration of this pharmaceutical agent?
4. Question: Which of the following is the least appropriate medication for a patient with suspected increased intracranial pressure?
5. Question: It is noted that a trauma ICU patient is receiving adequate pain relief during painful procedures, but has increased skeletal muscle tone, an elevation in HR and BP, and post-procedure hallucinations and agitation as the drug wears off. Which of the following pharmaceutical agents is likely to create these effects?
6. Question: You are managing a patient who presented to the emergency department with a severe headache. Shortly upon arrival, the patient’s neurological status rapidly deteriorates requiring airway management. Rapid sequence intubation is performed, and the patient suddenly develops a fever, hypertension, tachycardia, metabolic acidosis, hyperkalemia, and muscle rigidity. Which induction agent was most likely used?
7. Question: You are selecting a neuromuscular blocking agent with the least cardiovascular side effect profile for an elderly patient with coronary artery disease. Which of the following medications should be avoided?
8. Question: Your ICU patient is admitted following multisystem trauma secondary to a motor vehicle collision. The patient is ventilated and will be maintained on a neuromuscular blocking continuous agent to maintain neuromuscular blockage and deep sedation. Which of the following is a true statement?
9. Question: Which of the following best describes the rationale for long-term methadone therapy in treating opioid addiction and abuse?
10. Question: Which of the following is a pure opioid antagonist that binds competitively to opioid receptors, does not produce analgesia or opioid side effects, and reverses the toxic effects of agonist and agonist-antagonist opioids?